Riccardo S.
- Country
- France
- Department
- Oncology
Research Overview
- Phase 3 Randomized Open-Label Study of OP-1250 Versus Standard of Care in ER+, HER2- Advanced or Metastatic Breast Cancer Post-Endocrine and CDK4/6 Inhibitor Therapy
- Phase 3 Randomized Study of Zanidatamab Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in Metastatic HER2-Positive Breast Cancer
Data & Insights
Has run more than one trial at 30 of 144 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in advanced therapeutic approaches for ER-positive, HER2-negative metastatic breast cancer, with particular emphasis on treatment strategies for patients who have undergone prior endocrine therapy.
- Advanced Breast Cancer Treatment
- Hormone Receptor-Positive Disease
- Metastatic Disease Management
The investigator's research interests encompass innovative therapeutic interventions for breast cancer patients who have progressed after CDK 4/6 inhibitor therapy.
Endocrine Therapy
The investigator focuses on developing novel approaches in endocrine therapy resistance, exploring new treatment options for patients who have experienced disease progression following standard hormonal treatments.
- Resistance Mechanisms
- Treatment Sequencing
- Novel Therapeutic Agents
Their work includes evaluation of emerging therapies for patients with hormone receptor-positive breast cancer requiring advanced treatment options.
Clinical Assessment
The investigator specializes in treatment efficacy evaluation through sophisticated clinical assessment methodologies, including the use of blinded independent review committees for progression-free survival analysis.
- Safety Assessment
- Treatment Comparison
- Clinical Outcomes
Their expertise includes rigorous evaluation of novel therapeutic agents against established standards of care in advanced breast cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.